| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$22,658,153 |
|
|
|
Indirect Value
|
$2,507,138 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$25,165,291 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-02-13 |
4 |
AS |
$87.66 |
$336,790 |
D/D |
(3,842) |
130,080 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-05-15 |
4 |
AS |
$114.92 |
$33,786 |
D/D |
(294) |
126,238 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2017-05-25 |
4 |
A |
$1.74 |
$39,999 |
D/D |
22,988 |
22,988 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-06-01 |
4 |
OE |
$37.86 |
$4,334,887 |
D/D |
98,553 |
224,791 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-06-01 |
4 |
AS |
$124.00 |
$12,220,572 |
D/D |
(98,553) |
126,238 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$19,867,400 |
D/D |
(123,400) |
126,238 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-19 |
4 |
OE |
$77.31 |
$10,379,726 |
D/D |
123,400 |
249,638 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-21 |
4 |
AS |
$157.56 |
$1,663,413 |
D/D |
(10,350) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-31 |
4 |
OE |
$83.36 |
$177,140 |
D/D |
2,125 |
118,013 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-31 |
4 |
AS |
$152.24 |
$324,865 |
D/D |
(2,125) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
118,043 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-02 |
4 |
AS |
$152.49 |
$332,236 |
D/D |
(2,155) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-07 |
4 |
AS |
$154.09 |
$660,415 |
D/D |
(4,250) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-07 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
120,138 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-10-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
118,013 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-10-16 |
4 |
AS |
$154.01 |
$330,671 |
D/D |
(2,125) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-10-31 |
4 |
AS |
$142.40 |
$10,879,858 |
D/D |
(75,000) |
40,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-11-03 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
43,043 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-11-03 |
4 |
AS |
$150.00 |
$323,250 |
D/D |
(2,155) |
40,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-11-06 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
45,138 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-11-06 |
4 |
AS |
$150.00 |
$637,500 |
D/D |
(4,250) |
40,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-11-15 |
4 |
AS |
$147.29 |
$1,031 |
D/D |
(7) |
40,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-01-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
43,013 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-01-16 |
4 |
AS |
$155.80 |
$334,232 |
D/D |
(2,125) |
40,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
23,607 |
64,495 |
0 |
- |
|
128 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
